C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/47 (2006.01) A61P 29/00 (2006.01) C07D 207/26 (2006.01)
Patent
CA 2361848
The present application describes novel lactams and derivatives thereof of formula (I) or pharmaceutically acceptable salt forms thereof, wherein ring B is a 4-8 membered lactam containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as inhibitors of matrix metalloproteinases, TNF-.alpha., and aggrecanase.
La présente invention concerne de nouveaux lactames et des dérivés de ceux-ci de formule (I), ou des formes salines pharmaceutiquement acceptables de ceux-ci, le cycle B représentant un lactame avec 4 à 8 chaînons qui contient de 0 à 3 hétéroatomes supplémentaires choisis parmi N, O, et S, ces nouveaux lactames et leurs dérivés pouvant être utilisés comme inhibiteurs de métalloprotéases matricielles, de TNF-alpha, et de l'aggrécanase.
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
Dupont Pharmaceuticals Company
LandOfFree
Novel lactam inhibitors of matrix metalloproteinases,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel lactam inhibitors of matrix metalloproteinases,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel lactam inhibitors of matrix metalloproteinases,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2043499